Propanc Biopharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,820,528 over the previous period. Total operating expenses were $1,501,899.

Profit Margin

Propanc Biopharma, Inc. (OTC:PPCB): Profit margin
2015 0 -3.41M
2016 0 -9.41M
2017 0 -7.86M
2018 0 -7.03M
2019 0 -5.75M
2020 0 -4.74M
2021 0 -2.02M
2022 0 -2.65M
2023 0 -3.13M
2024 0 -1.82M

PPCB Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000000000
Cost of revenue
34.15K28.84K28.36K28.11K32.80K28.06K30.52K2.16K8773.71K
Gross profit
-34.15K-28.84K-28.36K-28.11K-32.80K-28.06K-30.52K-2.16K-877-3.71K
Operating exp.
Research and development
248.10K247.91K256.05K230.95K179.98K260.33K1.82M971.76K1.44M134.31K
Selling and marketing
34.15K28.84K00000000
Total operating expenses
1.50M1.77M1.99M1.81M3.49M2.61M3.95M5.74M6.89M1.70M
Operating income
-1.53M-1.77M-1.99M-1.81M-3.49M-2.61M-3.95M-5.74M-6.89M-1.70M
Other income (expenses), net
-413.61K-1.01M-722.19K-327.21K-1.38M-3.25M-469.41K-2.43M1.89M-1.78M
Income before tax
-1.94M-2.79M-2.71M-2.13M-4.87M-5.87M-7.21M-8.17M-9.48M-3.49M
Income tax expense
-129.13K-129.84K-54.97K-113.41K-134.72K-115.43K-179.30K-305.67K-72.53K-77.47K
Net income
-1.82M-3.13M-2.65M-2.02M-4.74M-5.75M-7.03M-7.86M-9.41M-3.41M
Earnings per share
Basic EPS
-0.02-1.79-39.09-668.19-192.45K-5.75M-76.51K-1.11B-1.88M-0.25
Diluted EPS
-0.02-1.79-38.96-668.19-192.45K-5.75M-76.51K-1.11B-1.88M-0.25
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source